These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11994701)
21. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267 [TBL] [Abstract][Full Text] [Related]
22. The effect of loratadine in exercise-induced asthma. Baki A; Orhan F Arch Dis Child; 2002 Jan; 86(1):38-9. PubMed ID: 11806881 [TBL] [Abstract][Full Text] [Related]
23. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Reimers A; Pichler C; Helbling A; Pichler WJ; Yawalkar N Clin Exp Allergy; 2002 Dec; 32(12):1763-8. PubMed ID: 12653169 [TBL] [Abstract][Full Text] [Related]
25. Summary of clinical trials with zafirlukast. Calhoun WJ Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606 [TBL] [Abstract][Full Text] [Related]
26. Protection against histamine-induced bronchoconstriction by loratadine. Debelić M Allergol Immunopathol (Madr); 1992; 20(3):97-100. PubMed ID: 1357946 [TBL] [Abstract][Full Text] [Related]
27. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. Smith LJ; Hanby LA; Lavins BJ; Simonson SG Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. Phipatanakul W; Eggleston PA; Conover-Walker MK; Kesavanathan J; Sweitzer D; Wood RA J Allergy Clin Immunol; 2000 Apr; 105(4):704-10. PubMed ID: 10756219 [TBL] [Abstract][Full Text] [Related]
29. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of a leukotriene receptor antagonist in the treatment of perennial allergic rhinitis. Jiang RS J Otolaryngol; 2006 Apr; 35(2):117-21. PubMed ID: 16527031 [TBL] [Abstract][Full Text] [Related]
31. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Reiss TF; Hill JB; Harman E; Zhang J; Tanaka WK; Bronsky E; Guerreiro D; Hendeles L Thorax; 1997 Dec; 52(12):1030-5. PubMed ID: 9516894 [TBL] [Abstract][Full Text] [Related]
32. [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction]. Sun TY; Guo YF; Xu XM; Zhang HS; Hou J; Ke HX; Li YM; Fang BM; Ming SH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):83-7. PubMed ID: 15854387 [TBL] [Abstract][Full Text] [Related]
33. Effect of zafirlukast on cough reflex sensitivity in asthmatics. Dicpinigaitis PV; Dobkin JB J Asthma; 1999 May; 36(3):265-70. PubMed ID: 10350223 [TBL] [Abstract][Full Text] [Related]
34. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. Bagenstose SE; Levin L; Bernstein JA J Allergy Clin Immunol; 2004 Jan; 113(1):134-40. PubMed ID: 14713918 [TBL] [Abstract][Full Text] [Related]
35. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789 [TBL] [Abstract][Full Text] [Related]
36. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Virchow JC; Prasse A; Naya I; Summerton L; Harris A Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090 [TBL] [Abstract][Full Text] [Related]
37. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile]. Murata Y; Sugimoto O Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731 [TBL] [Abstract][Full Text] [Related]
38. The effect of GSK2190915, a 5-lipoxygenase-activating protein inhibitor, on exercise-induced bronchoconstriction. Kent SE; Bentley JH; Miller D; Sterling R; Menendez R; Tarpay M; Pearlman DS; Norris V Allergy Asthma Proc; 2014; 35(2):126-33. PubMed ID: 24717789 [TBL] [Abstract][Full Text] [Related]
39. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658 [TBL] [Abstract][Full Text] [Related]
40. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses. Tashkin DP; Nathan RA; Howland WC; Minkwitz MC; Simonson SG; Bonuccelli CM J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):246-54. PubMed ID: 9949315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]